SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Nova Cannabis Inc. NVACF OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Nova Cannabis Inc. (NVACF) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $1.26. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Financials: revenue is $259M, +207.4%/yr average growth. Net income is $3M, growing at +16.8%/yr. Net profit margin is 1.2% (thin). Gross margin is 19.4% (-11 pp trend).

Balance sheet: total debt is $64M against $51M equity (Debt-to-Equity (D/E) ratio 1.26, moderate). Current ratio is 1.22 (adequate). Debt-to-assets is 51.5%. Total assets: $124M.

SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 90/100 (Pass), Past 25/100 (Fail), Health 33/100 (Fail), Moat 15/100 (Fail), Future ?/100 (Fail), Income 30/100 (Fail).

NVACF SharesGrow Score Overview

45/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 75/100

Valuation — P/E, PEG, Forward PEG

GROWTH 90/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 33/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 15/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NVACF

NVACF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

NVACF: +207.4%/yr revenue is, +16.8%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

NVACF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet NVACF: Debt-to-Equity (D/E) ratio 1.26 (moderate), Current ratio is 1.22 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

NVACF: Gross margin is 19.4% (-11 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 15/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

NVACF: Net profit margin is 1.2%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range1.25-1.308

Volume8.4K

Avg Volume (30D)5.15K

Market Cap$78.47M

Beta (1Y)-2.06

Share Statistics

EPS (TTM)0.05

Shares Outstanding$57.19M

IPO Date2021-03-24

Employees719

CEOGrant Sanderson

Financial Highlights & Ratios

Revenue (TTM)$259.33M

Gross Profit$50.2M

EBITDA$19.05M

Net Income$3.03M

Operating Income$9.91M

Total Cash$13.81M

Total Debt$64.02M

Net Debt$50.21M

Total Assets$124.4M

Price / Earnings (P/E)23.9

Price / Sales (P/S)0.3

Analyst Forecast

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

ISINCA66980W1041

Price Chart

NVACF

Nova Cannabis Inc. ↗ · Other OTC

Healthcare • Medical - Pharmaceuticals

1.25 52WK RANGE 1.31

People Also View

Leafly Holdings, Inc.

TRxADE HEALTH, Inc.

SunLink Health Systems, Inc.

Fire & Flower Holdings Corp.

HealthWarehouse.com, Inc.

Leafly Holdings, Inc.

Kiaro Holdings Corp.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message